Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:408-413

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imig, J. D.
Right arrow Articles by Falck, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imig, J. D.
Right arrow Articles by Falck, J. R.

(Hypertension. 1999;33:408-413.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Afferent Arteriolar Vasodilation to the Sulfonimide Analog of 11,12-Epoxyeicosatrienoic Acid Involves Protein Kinase A

John D. Imig; Edward W. Inscho; Paul C. Deichmann; K. Malla Reddy; John R. Falck

From the Department of Physiology, Tulane University School of Medicine, New Orleans, La (J.D.I., E.W.I., P.C.D.); and the Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Tex (K.M.R., J.R.F.).

Correspondence to John D. Imig, PhD, Department of Physiology, SL39, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112. E-mail jdimig{at}mailhost.tcs.tulane.edu

Abstract—The current study determined the contribution of protein kinase-A (PKA) and protein kinase-G (PKG) to the vasodilation elicited by the N-methylsulfonimide analog of 11,12-epoxyeicosatrienoic acid (11,12-EET). Experiments were performed, in vitro, using the juxtamedullary nephron preparation combined with videomicroscopy. The response of afferent arterioles to the sulfonimide analog of 11,12-EET, was determined before and after inhibition of PKA, PKG, or guanylyl cyclase. Afferent arterioles, preconstricted with 0.5 µmol/L norepinephrine, averaged 18±1 µm (n=25) at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nmol/L of the 11,12-EET analog caused a graded increase in diameter of the afferent arteriole. Vessel diameter increased by 11±1% and 15±1%, respectively, in response to 10 and 100 nmol/L of the 11,12-EET analog. The afferent arteriolar response to 10 and 100 nmol/L of the 11,12-EET analog was significantly attenuated during inhibition of PKA with 10 µmol/L H-89 (n=7) or 5 µmol/L myristolated PKI (n=6), such that afferent arteriolar diameter increased by only 5±2% and 2±1%, respectively, in response to 100 nmol/L of the 11,12-EET analog. In contrast, the afferent arteriolar vasodilatory response to the 11,12-EET analog was unaffected by PKG or guanylyl cyclase inhibition. In the presence of 200 µmol/L histone H2B (n=5) or 10 µmol/L ODQ (n=7), the afferent arteriolar diameter increased by 16±3% and 12±2%, respectively, in response to 100 nmol/L of the 11,12-EET analog. These results demonstrate that activation of PKA is an important mechanism responsible for the afferent arteriolar vasodilation elicited by the sulfonimide analog of 11,12-EET.


Key Words: metabolites, cytochrome P450 • kidney • endothelium-derived hyperpolarizing factor • arterioles • cyclic adenosine monophosphate • cyclic guanosine monophosphate




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. E. Loot, R. Popp, B. Fisslthaler, J. Vriens, B. Nilius, and I. Fleming
Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation
Cardiovasc Res, December 1, 2008; 80(3): 445 - 452.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
U. R. Michaelis, N. Xia, E. Barbosa-Sicard, J. R. Falck, and I. Fleming
Role of Cytochrome P450 2C Epoxygenases in Hypoxia-Induced Cell Migration and Angiogenesis in Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Fleming, A. Rueben, R. Popp, B. Fisslthaler, S. Schrodt, A. Sander, J. Haendeler, J. R. Falck, C. Morisseau, B. D. Hammock, et al.
Epoxyeicosatrienoic Acids Regulate Trp Channel Dependent Ca2+ Signaling and Hyperpolarization in Endothelial Cells
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2612 - 2618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Williams, M. Sharma, S. Anjaiahh, J. R. Falck, and R. J. Roman
Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F501 - F505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Sacerdoti, M. Bolognesi, M. Di Pascoli, A. Gatta, J. C. McGiff, M. L. Schwartzman, and N. G. Abraham
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1999 - H2002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff
Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Ye, W. Zhou, T. Lu, S. G. Jagadeesh, J. R. Falck, and H.-C. Lee
Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1326 - H1336.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Fleming and R. Busse
Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function
Hypertension, April 1, 2006; 47(4): 629 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. B. Davis, C. Morisseau, J. W. Newman, T. L. Pedersen, B. D. Hammock, and R. H. Weiss
Attenuation of Vascular Smooth Muscle Cell Proliferation by 1-Cyclohexyl-3-dodecyl Urea Is Independent of Soluble Epoxide Hydrolase Inhibition
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
U. R. Michaelis, B. Fisslthaler, E. Barbosa-Sicard, J. R. Falck, I. Fleming, and R. Busse
Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis
J. Cell Sci., December 1, 2005; 118(23): 5489 - 5498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. R. Michaelis, J. R. Falck, R. Schmidt, R. Busse, and I. Fleming
Cytochrome P4502C9-Derived Epoxyeicosatrienoic Acids Induce the Expression of Cyclooxygenase-2 in Endothelial Cells
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 321 - 326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Ye, W. Zhou, and H.-C. Lee
Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H358 - H364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1064 - H1071.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. D. Snyder, U. M. Krishna, J. R. Falck, and A. A. Spector
Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1936 - H1942.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
To Move or Not To Move?: Cytochrome P450 Products and Cell Migration
Circ. Res., May 17, 2002; 90(9): 936 - 938.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Sun, X. Sui, J. A. Bradbury, D. C. Zeldin, M. S. Conte, and J. K. Liao
Inhibition of Vascular Smooth Muscle Cell Migration by Cytochrome P450 Epoxygenase-Derived Eicosanoids
Circ. Res., May 17, 2002; 90(9): 1020 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Potente, U. R. Michaelis, B. Fisslthaler, R. Busse, and I. Fleming
Cytochrome P450 2C9-induced Endothelial Cell Proliferation Involves Induction of Mitogen-activated Protein (MAP) Kinase Phosphatase-1, Inhibition of the c-Jun N-terminal Kinase, and Up-regulation of Cyclin D1
J. Biol. Chem., May 3, 2002; 277(18): 15671 - 15676.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Popp, R. P. Brandes, G. Ott, R. Busse, and I. Fleming
Dynamic Modulation of Interendothelial Gap Junctional Communication by 11,12-Epoxyeicosatrienoic Acid
Circ. Res., April 19, 2002; 90(7): 800 - 806.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Lauterbach, E. Barbosa-Sicard, M.-H. Wang, H. Honeck, E. Kargel, J. Theuer, M. L. Schwartzman, H. Haller, F. C. Luft, M. Gollasch, et al.
Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators
Hypertension, February 1, 2002; 39(2): 609 - 613.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
Cytochrome P450 and Vascular Homeostasis
Circ. Res., October 26, 2001; 89(9): 753 - 762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Benoit, B. Renaudon, D. Salvail, and E. Rousseau
EETs relax airway smooth muscle via an EpDHF effect: BKCa channel activation and hyperpolarization
Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L965 - L973.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Ito, K. Omata, S. Ito, K. M. Hoagland, and R. J. Roman
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R822 - R830.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Fukao, H. S. Mason, J. L. Kenyon, B. Horowitz, and K. D. Keef
Regulation of BKca Channels Expressed in Human Embryonic Kidney 293 Cells by Epoxyeicosatrienoic Acid
Mol. Pharmacol., January 1, 2001; 59(1): 16 - 23.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Eicosanoid regulation of the renal vasculature
Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Alonso-Galicia, J. R. Falck, K. M. Reddy, and R. J. Roman
20-HETE agonists and antagonists in the renal circulation
Am J Physiol Renal Physiol, November 1, 1999; 277(5): F790 - F796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Node, X.-L. Ruan, J. Dai, S.-X. Yang, L. Graham, D. C. Zeldin, and J. K. Liao
Activation of Galpha s Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic Acids
J. Biol. Chem., May 4, 2001; 276(19): 15983 - 15989.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Popp, R. P. Brandes, G. Ott, R. Busse, and I. Fleming
Dynamic Modulation of Interendothelial Gap Junctional Communication by 11,12-Epoxyeicosatrienoic Acid
Circ. Res., April 19, 2002; 90(7): 800 - 806.
[Abstract] [Full Text] [PDF]